The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients

Mona S Abdellateif,1 Salem E Salem,2 Doaa M Badr,3 Sabry Shaarawy,1 Marwa M Hussein,2 Abdel-Rahman N Zekri,4 Mariam A Fouad3 1Medical Biochemistry and Molecular Biology, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt; 2Medical Oncology Department, National Cance...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Abdellateif MS, Salem SE, Badr DM, Shaarawy S, Hussein MM, Zekri AN, Fouad MA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	colorectal cancer 5- fluorouracil cox2 egfr interleukins survival tnfα. Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/51f40735f2484af28b6d63e16381923b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:51f40735f2484af28b6d63e16381923b
record_format	dspace
spelling	oai:doaj.org-article:51f40735f2484af28b6d63e16381923b2021-12-02T10:40:53ZThe Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients1178-7031https://doaj.org/article/51f40735f2484af28b6d63e16381923b2020-12-01T00:00:00Zhttps://www.dovepress.com/the-prognostic-significance-of-5-fluorouracil-induced-inflammation-and-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Mona S Abdellateif,1 Salem E Salem,2 Doaa M Badr,3 Sabry Shaarawy,1 Marwa M Hussein,2 Abdel-Rahman N Zekri,4 Mariam A Fouad3 1Medical Biochemistry and Molecular Biology, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt; 2Medical Oncology Department, National Cancer Institute, Cairo, Egypt; 3Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt; 4Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo, EgyptCorrespondence: Mariam A FouadPharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cairo Institute, Cairo University, 1Kasr AlAini Street, Fom Elkalig, Cairo 11796, EgyptEmail Mariam.fouad@nci.cu.edu.egAim: The change in the levels of peripheral inflammatory markers together with EGFR in relation to 5- fluorouracil (5-FU) therapy was evaluated for their prognostic significance in colorectal cancer (CRC) patients.Patients and Methods: Expression levels of COX2, IL6, IL1β, EGFR, IL10, and TNFα were determined with quantitative real-time PCR (qPCR) in the peripheral blood of 90 CRC patients. The inflammatory response was correlated with patients’ clinical features, disease-free survival (DFS), and overall survival (OS).Results: After 6 months of 5-FU therapy, increased inflammatory response was found to be associated with smoking, T3 or T4 tumors, performance status (PS) III, positive lymph nodes, distant metastasis, and gastrointestinal (GIT) toxicity. The combination of COX2 with interleukins in a predictive equation for DFS was significant in patients with over-expression of EGFR. DFS and OS rates were reduced in patients with increased COX2, IL6, IL10, and TNFα expression with 5-FU therapy. Significant hazard of disease progression was associated with smoking (HR=1.27, P=0.004), 5-FU induction of COX2, and IL6 expression (HR=1.35, P=0.001 and HR=1.27, P=0.004, respectively). Moreover, smoking, 5-FU induction of IL6, TNFα, and IL10 expression are found to be independent prognostic factors for OS (P=0.003, 0.003, 0.002, and 0.002, respectively).Conclusion: The peripheral effects of 5-FU therapy have shown a significant impact on the treatment outcome of CRC patients.Keywords: colorectal cancer, 5-fluorouracil, COX2, EGFR, interleukins, survival, TNFαAbdellateif MSSalem SEBadr DMShaarawy SHussein MMZekri ANFouad MADove Medical Pressarticlecolorectal cancer5- fluorouracilcox2egfrinterleukinssurvivaltnfα.PathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 13, Pp 1245-1259 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	colorectal cancer 5- fluorouracil cox2 egfr interleukins survival tnfα. Pathology RB1-214 Therapeutics. Pharmacology RM1-950
spellingShingle	colorectal cancer 5- fluorouracil cox2 egfr interleukins survival tnfα. Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Abdellateif MS Salem SE Badr DM Shaarawy S Hussein MM Zekri AN Fouad MA The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients
description	Mona S Abdellateif,1 Salem E Salem,2 Doaa M Badr,3 Sabry Shaarawy,1 Marwa M Hussein,2 Abdel-Rahman N Zekri,4 Mariam A Fouad3 1Medical Biochemistry and Molecular Biology, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt; 2Medical Oncology Department, National Cancer Institute, Cairo, Egypt; 3Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt; 4Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo, EgyptCorrespondence: Mariam A FouadPharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cairo Institute, Cairo University, 1Kasr AlAini Street, Fom Elkalig, Cairo 11796, EgyptEmail Mariam.fouad@nci.cu.edu.egAim: The change in the levels of peripheral inflammatory markers together with EGFR in relation to 5- fluorouracil (5-FU) therapy was evaluated for their prognostic significance in colorectal cancer (CRC) patients.Patients and Methods: Expression levels of COX2, IL6, IL1β, EGFR, IL10, and TNFα were determined with quantitative real-time PCR (qPCR) in the peripheral blood of 90 CRC patients. The inflammatory response was correlated with patients’ clinical features, disease-free survival (DFS), and overall survival (OS).Results: After 6 months of 5-FU therapy, increased inflammatory response was found to be associated with smoking, T3 or T4 tumors, performance status (PS) III, positive lymph nodes, distant metastasis, and gastrointestinal (GIT) toxicity. The combination of COX2 with interleukins in a predictive equation for DFS was significant in patients with over-expression of EGFR. DFS and OS rates were reduced in patients with increased COX2, IL6, IL10, and TNFα expression with 5-FU therapy. Significant hazard of disease progression was associated with smoking (HR=1.27, P=0.004), 5-FU induction of COX2, and IL6 expression (HR=1.35, P=0.001 and HR=1.27, P=0.004, respectively). Moreover, smoking, 5-FU induction of IL6, TNFα, and IL10 expression are found to be independent prognostic factors for OS (P=0.003, 0.003, 0.002, and 0.002, respectively).Conclusion: The peripheral effects of 5-FU therapy have shown a significant impact on the treatment outcome of CRC patients.Keywords: colorectal cancer, 5-fluorouracil, COX2, EGFR, interleukins, survival, TNFα
format	article
author	Abdellateif MS Salem SE Badr DM Shaarawy S Hussein MM Zekri AN Fouad MA
author_facet	Abdellateif MS Salem SE Badr DM Shaarawy S Hussein MM Zekri AN Fouad MA
author_sort	Abdellateif MS
title	The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients
title_short	The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients
title_full	The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients
title_fullStr	The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients
title_full_unstemmed	The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients
title_sort	prognostic significance of 5-fluorouracil induced inflammation and immuno-modulation in colorectal cancer patients
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/51f40735f2484af28b6d63e16381923b
work_keys_str_mv	AT abdellateifms theprognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT salemse theprognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT badrdm theprognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT shaarawys theprognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT husseinmm theprognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT zekrian theprognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT fouadma theprognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT abdellateifms prognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT salemse prognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT badrdm prognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT shaarawys prognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT husseinmm prognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT zekrian prognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients AT fouadma prognosticsignificanceof5fluorouracilinducedinflammationandimmunomodulationincolorectalcancerpatients
_version_	1718396826105675776

The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients

Ejemplares similares